Poolbeg Pharma PLC has announced the grant of its first national patent covering the POLB-001 programme, which addresses cytokine release syndrome induced by cancer immunotherapy. The development represents a significant
All posts tagged in POLB 001
3Articles
Shares in Poolbeg Pharma PLC climbed as much as 10% during Tuesday morning trading following confirmation that the company has secured its first national patent grant for POLB 001, its
Poolbeg Pharma has concluded a transformative year marked by substantial progress across its clinical pipeline, according to chief executive Jeremy Skillington in a recent interview. The biopharmaceutical company has advanced
